Chemokines as novel therapeutic targets in inflammatory diseases

Biochemical Pharmacology

Volumn 63, Issue 7, 2002, Pages 1191-1196

  Ajuebor, Maureen N ^a   Swain, Mark G ^a   Perretti, Mauro ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Chemokine receptor antagonists; Chemokine receptors; Chemokines; Inflammation; Inflammatory disease; Leukocytes

Indexed keywords

ALPHA CHEMOKINE; ANTIBODY; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR3; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; INTERLEUKIN 8; INTERLEUKIN 8 ANTIBODY; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; RANTES ANTIBODY; RECEPTOR BLOCKING AGENT; THYMUS AND ACTIVATION REGULATED CHEMOKINE; UNCLASSIFIED DRUG;

ATHEROSCLEROSIS; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; ENTERITIS; GASTROINTESTINAL DISEASE; GRAFT REJECTION; HELICOBACTER INFECTION; HUMAN; INFLAMMATORY DISEASE; LIVER DISEASE; MULTIPLE SCLEROSIS; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; RHEUMATOID ARTHRITIS; SEPSIS; TREATMENT OUTCOME;

EID: 0036535980     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(02)00854-7     Document Type: Note

References (56)

1. Dancing to the tune of chemokines
2. Chemokines-chemotactic cytokines that mediate inflammation
3. Chemokines and leukocyte traffic
4. Chemokines and disease
5. International union of pharmacology. XXII. Nomenclature for chemokine receptors
6. Role of chemokines and chemokine receptors in the gastrointestinal tract
7. Chemokines, chemokine receptors, and allograft rejection
8. Chemokine receptor antagonism as a new therapy for multiple sclerosis
9. Chemokines as molecular targets for therapeutic intervention
10. The strategy of blocking the chemokine system to combat disease
11. Viral exploitation and subversion of the immune system through chemokine mimicry
12. The role of chemokines in the immunopathology of the liver
13. Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration
14. Chemokine levels in human liver homogenates: Associations between GRO alpha and histopathological evidence of alcoholic hepatitis
15. Serum levels of interleukin-8 in alcoholic liver disease: Relationship with disease stage, biochemical parameters and survival
16. Monocyte chemotactic protein-1, -2, and -3 are distinctively expressed in portal tracts and granulomata in primary biliary cirrhosis: Implications for pathogenesis
17. Monocyte chemoattractant protein 1 (MCP-1) expression occurs in toxic rat liver injury and human liver disease
18. Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver
19. Increase of chemokine interferon-inducible protein-10 (IP-10) in the serum of patients with autoimmune liver diseases and increase of its mRNA expression in hepatocytes
20. Pivotal role of TARC, a CC chemokine in bacteria-induced fulminant hepatic failure in mice
21. The role of cytokine networks in the local liver injury following hepatic ischemia/reperfusion in the rat
22. Chemokine involvement in hepatic ischemia/reperfusion injury in mice: Roles for macrophage inflammatory protein-2 and KC
23. + T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease
24. Novel CXCR2-dependent liver regenerative qualities of ELR-containing CXC chemokines
25. Exaggerated hepatic injury due to acetaminophen challenge in mice lacking C-C chemokine receptor 2
26. Polyclonal antibody directed against human RANTES ameliorates disease in the Lewis rat adjuvant-induced arthritis model
27. Temporal expression of inflammatory cytokines and chemokines in rat adjuvant-induced arthritis
28. The chemoattractant activity of rheumatoid synovial fluid for human lymphocytes is due to multiple cytokines
29. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions
30. An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model
31. Effect of a CC chemokine receptor antagonist on collagen-induced arthritis in DBA/1 mice
32. The role of an epithelial neutrophil-activating peptide-78-like protein in rat adjuvant-induced arthritis
33. Attenuation of monosodium urate crystal-induced arthritis in rabbits by a neutralizing antibody against interleukin-8
34. The murine homolog of the interleukin-8 receptor CXCR-2 is essential for the occurrence of neutrophilic inflammation in the air pouch model of acute urate crystal-induced gouty synovitis
35. POMC gene-derived peptides activate melanocortin type 3 receptor on murine macrophages, suppress cytokine release, and inhibit neutrophil migration in acute experimental inflammation
36. Chemokines and chemokine receptors in inflammation of the nervous system: Manifold roles and exquisite regulation
37. CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis
38. Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2
39. Leukocyte recruitment during onset of experimental allergic encephalomyelitis is CCR1 dependent
40. Induction of experimental autoimmune encephalomyelitis in C57BL/6 mice deficient in either the chemokine macrophage inflammatory protein-1α or its CCR5 receptor
41. The CCR5 deletion mutation fails to protect against multiple sclerosis
42. + T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis
43. Hypotheses on the pathogenesis and natural history of Helicobacter pylori-induced inflammation
44. Helicobacter pylori-associated gastric ulcer exhibits enhanced mucosal chemokine activity at the ulcer site
45. Effect of urease on HeLa cell vacuolation induced by Helicobacter pylori cytotoxin
46. CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines
47. Expression of interleukin 8 and CD54 by human gastric epithelium after Helicobacter pylori infection in vitro
48. CXC chemokines Groα/IL-8 and IP-10/MIG in Helicobacter pylori gastritis
49. Comparison of CXC chemokines ENA-78 and interleukin-8 expression in Helicobacter pylori-associated gastritis
50. Interleukin-8 activity correlates with histological severity in Helicobacter pylori-associated antral gastritis
51. Chemokine mRNA expression in gastric mucosa is associated with Helicobacter pylori cagA positivity and severity of gastritis
52. Gastric corpus IL-8 concentration and neutrophil infiltration in duodenal ulcer patients
53. Gastric metaplasia in the duodenal bulb shows increased mucosal interleukin-8 activity in Helicobacter pylori-positive duodenal ulcer patients
54. BCA-1 is highly expressed in Helicobacter pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma
55. Mucosal chemokine activity in Helicobacter pylori infection
56. The relationship between persistent secretion of RANTES and residual infiltration of eosinophils and memory T lymphocytes after Helicobacter pylori eradication